Popular Items
Order now for pickup or delivery
Our current specials
Dont miss out!
Mounjaro
Mounjaro contains the active ingredient tirzepatide, a GLP-1 and GIP receptor agonist. It behaves like the natural hormones GLP-1 and GIP to lower blood glucose concentrations, slow gastric emptying, regulate appetite and decrease food intake.
Mounjaro is a prescription medicine, and requires a prescription from a New Zealand registered healthcare professional.
The starting dose of Mounjaro is 2.5 mg once weekly. After 4 weeks, a prescribing healthcare professional may increase the dose to 5 mg once weekly, the first maintenance dose. Subsequent dose increases are to be determined by a prescribing healthcare professional.
Payment. Payment upon receipt of goods, Payment by card in the department, Google Pay, Online card, -5% discount in case of payment
Warranty. The Consumer Protection Act does not provide for the return of this product of proper quality.
Description
Mounjaro contains the active ingredient tirzepatide, a GLP-1 and GIP receptor agonist. It behaves like the natural hormones GLP-1 and GIP to lower blood glucose concentrations, slow gastric emptying, regulate appetite and decrease food intake.
Mounjaro is a prescription medicine, and requires a prescription from a New Zealand registered healthcare professional.
The starting dose of Mounjaro is 2.5 mg once weekly. After 4 weeks, a prescribing healthcare professional may increase the dose to 5 mg once weekly, the first maintenance dose. Subsequent dose increases are to be determined by a prescribing healthcare professional.
How does Mounjaro work?
Mounjaro contains a long-acting receptor agonist that targets GIP and GLP-1 receptors throughout the body.
- Reduces glucose concentrations when fasting and after eating
- Feeling fuller after eating
- Reduces appetite and food intake
Who can use Mounjaro?
Mounjaro is approved for adults who are living with:
- Insufficiently controlled type 2 diabetes mellitus
- Obesity (BMI ≥30 kg/m²), or
- Overweight (≥27 kg/m² to <30 kg/m²) with at least one weight-related comorbid condition (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes mellitus)
Mounjaro is a prescription medicine. Your doctor will review your health status and eligibility as part of an assessment.
How is Mounjaro administered?
- Administration: A once weekly subcutaneous (under the skin) injection
- Maintenance doses: 5 mg once weekly, 10 mg once weekly or 15 mg once weekly, as determined by your doctor.
- Additional care:
- Type 2 diabetes: Mounjaro is prescribed in combination with diet and exercise. Your doctor may prescribe Mounjaro in addition to an existing diabetes medicine.
- Obesity and overweight: Mounjaro is prescribed in combination with a reduced-calorie diet and increased physical activity.
- Use the KwikPen multi-use, prefilled pen
- Inject into thigh (front upper leg) or stomach (abdomen)
- On the same day each week if you can. This day can be changed, if necessary, as long as the time between two doses is at least 3 days (72 hours)
- You will need to purchase needle tips separately as these are not included with the Mounjaro KwikPen
- The KwikPen must be primed before each injection. Follow the instructions in the Mounjaro KwikPen Instructions for Use leaflet
- It is normal to have leftover liquid in your KwikPen after the 4th and final dose. The KwikPen will not allow you to inject this liquid into your body
Side effects
- Feeling sick (nausea)
- Diarrhoea
- Vomiting
- Abdominal (stomach) pain
- Feeling less hungry (decreased appetite)
- General feeling of tiredness
- Injection site reaction
- Hypoglycaemia (low blood sugar) when Mounjaro is used with certain medicines for type 2 diabetes mellitus
- Heartburn
- Indigestion (dyspepsia)
- Swelling or bloating of the stomach
- Constipation
- Burping or belching
- Farting (flatulence)
- Bloating and/or difficulty passing wind
- Dizziness
- Dehydration
- Hair loss
- Low blood pressure (hypotension)
- Increased pulse (heart rate)
- Changes to how foods or drinks taste
- Changes to sensation or unusual feelings of the skin
- Acute pancreatitis – Severe pain in the stomach or back that does not go away and vomiting and/or diarrhoea
- Allergic reactions – Symptoms may include rashes, itching and rapid swelling of the tissues of the neck, face, mouth and/or throat, hives, or problems breathing or swallowing
- Gallbladder complaints – Symptoms may include sudden, severe pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes, and clay-coloured stools
If you experience slowing down or blockage of your intestinal function, tell your doctor as soon as possible.
Managing side effects
- Follow your doctor’s instructions to start on a low dose and slowly increase to our maintenance dose
- Drink plenty of fluids
- Avoid fried and fatty foods
- Eat smaller meals
- Contact your doctor if side effects are severe or persistent
Safety information
- Are allergic to tirzepatide or any ingredients
- Are pregnant or planning to become pregnant
- Are breastfeeding
- Are using other weight loss products
Storage and handling
- Refrigeration: Store your Mounjaro KwikPen at 2°C to 8°C
- Room temperature: When refrigeration is not possible, you can store your KwikPen at room temperature (below 30°C) for up to 30 days
- Protection: Your Mounjaro KwikPen contains glass parts. Handle carefully. Do not use your Mounjaro KwikPen if it has been dropped on a hard surface
- Keep your Mounjaro KwikPen in its original package in order to protect it from light
- Do not allow your Mounjaro KwikPen to freeze.
Additional information
| Select | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
|---|
Reviews
There are no reviews yet.